Aditxt, Inc. - Common Stock (NQ:ADTX)

0.0095 UNCHANGED

Last Price Updated: 4:15 PM EDT, Jun 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aditxt, Inc. - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

September 12, 2022

We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning and the news moving them.

Via InvestorPlace

Why Clovis Oncology Is Trading Higher By 14%; Here Are 28 Stocks Moving Premarket ↗

September 12, 2022

Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 46.1% to $0.2801 in pre-market trading after jumping 37% on Friday.

Via Benzinga

Researchers Find Link Between Steroidal Allergy Treatments, Decreased Brain Function

September 08, 2022

Via Investor Brand Network

Why Is Aditxt (ADTX) Stock Up 74% Today? ↗

July 08, 2022

ADTX stock is soaring after the company reported positive results from a preclinical toxicology test this morning.

Via InvestorPlace

Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday ↗

September 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...

Via Benzinga

Study Finds Children Have Better Outcomes with Kidney Transplants from Living Donors

August 30, 2022

Via Investor Brand Network

Study Finds That Early Exposure to Antibiotics May Trigger Asthma, Permanent Allergies

August 23, 2022

Via Investor Brand Network

Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday ↗

August 22, 2022

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday on continued volatility following the company's IPO on Thursday.

Via Benzinga

Senate Review Reveals Screening Mistakes Caused Organ Transplant Failures, Illnesses, Deaths

August 15, 2022

Via Investor Brand Network

Why Is Turquoise Hill Resources Down By 18%: Here Are 31 Stocks Moving Premarket ↗

August 15, 2022

Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 31.2% to $0.6931 in pre-market trading as the company presented positive data from ongoing ReSPECT™ clinical trials at the Annual Conference...

Via Benzinga

BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Looking to Solve Medical Challenge in Immune Responses

August 12, 2022

Via Investor Brand Network

Why Is Toast Trading Higher By 20%: Here Are 34 Stocks Moving Premarket ↗

August 12, 2022

Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 66.9% to $2.37 in pre-market trading. Neptune Wellness Solutions recently announced voluntary delisting from Toronto Stock Exchange.

Via Benzinga

Combining Immunotherapy with Anti-Rejection Drugs Can Treat Cancer, Prevent Kidney Transplant Rejection

August 05, 2022

Via Investor Brand Network

BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Featured in Bell2Bell Podcast

August 02, 2022

Via Investor Brand Network

Aditxt Inc. (NASDAQ: ADTX) Seeks to Address Variability of Immune Responses

August 02, 2022

Via Investor Brand Network

Study Finds That Introducing Some Foods to Infants Early Reduces Risks of Allergies

July 28, 2022

Via Investor Brand Network

Study Highlights New Insights on Neurological Autoimmune Illnesses

July 19, 2022

Via Investor Brand Network

BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Equipping Physicians, Individuals with Comprehensive Immune System Views

July 14, 2022

Via Investor Brand Network

Why Is Ericsson Down By 9%? 22 Stocks Moving In Thursday's Pre-Market Session ↗

July 14, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 22.1% to $0.2050 in pre-market trading. Allena Pharmaceuticals disclosed a new meeting date and new record date for special meeting to approve...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 12, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 11, 2022

Via Benzinga

Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session ↗

July 11, 2022

Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.

Via Benzinga

Alibaba, Zoom Video And 76 Biggest Movers From Yesterday ↗

July 12, 2022

Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.

Via Benzinga

Why Is Twitter Down By More Than 5%? 22 Stocks Moving In Monday's Pre-Market Session ↗

July 11, 2022

Gainers Inpixon (NASDAQ: INPX) rose 25.8% to $0.2305 in pre-market trading after gaining more than 22% on Friday.

Via Benzinga

Tesla, Twitter And 76 Biggest Movers From Friday ↗

July 11, 2022

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...

Via Benzinga

Dow Rises 75 Points; Kura Sushi USA Shares Spike Higher ↗

July 08, 2022

U.S. stocks traded slightly higher toward the end of trading as investors digested the recent jobs report for the month of June.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 08, 2022

Via Benzinga

Dow Turns Positive After Better-Than-Expected Jobs Report ↗

July 08, 2022

U.S. stocks turned higher midway through as investors digested the recent jobs report for the month of June.

Via Benzinga

Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session ↗

July 08, 2022

Gainers Aditxt, Inc. (NASDAQ: ADTX) shares surged 75.7% to $0.2812 after the company's Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100.

Via Benzinga

BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Moves One Step Closer to In-Human Trials with Completion of Preclinical Toxicity Study

July 08, 2022

Via Investor Brand Network

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.